Antibiotic resistance in K. pneumoniae: perspectives, challenges, health risks, therapeutic approaches
Abstract
Klebsiella pneumoniae is an opportunistic Gram-negative pathogen of increasing global concern due to its expanding virulence potential and rapid acquisition of antimicrobial resistance. Traditionally associated with hospital-acquired infections such as pneumonia, urinary tract infections, and bloodstream infections, K. pneumoniae has evolved into a highly diverse species comprising classical (cKP), hypervirulent (hvKP), multidrug-resistant (MDR), and emerging carbapenem-resistant hypervirulent (CR-hvKP) variants. Its pathogenicity is driven by a wide array of virulence factors, including capsular polysaccharides, siderophores, fimbriae, lipopolysaccharides, and multiple secretion systems, all of which facilitate immune evasion, tissue invasion, biofilm formation, and environmental survival. Parallel to this, K. pneumoniae has developed extensive resistance through intrinsic mechanisms, such as efflux pumps and porin alterations, as well as acquired determinants including ESBLs, carbapenemases (KPC, NDM, and OXA-48), 16S rRNA methyltransferases, and plasmid-mediated mcr genes conferring colistin resistance. These combined traits have led to widespread dissemination of MDR and XDR strains, limiting therapeutic options and contributing to significant morbidity, mortality, and healthcare burdens worldwide. Epidemiologically, resistance hotspots have emerged in Asia, Europe, and the Middle East, while hvKP continues to expand beyond its original endemic regions. Diagnostic…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.